136 top medical experts on Sphingolipidoses across 12 countries and 6 U.S. states, including 6 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Sphingolipidoses: A group of inherited metabolic disorders characterized by the intralysosomal accumulation of sphingolipids primarily in the central nervous system and to a variable degree in the visceral organs. They are classified by the enzyme defect in the degradation pathway and the substrate accumulation (or storage). Clinical features vary in subtypes but neurodegeneration is a common sign.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Lipidoses (578), Nervous System Lysosomal Storage Diseases (88) and Narrower Categories: Fabry Disease (1,768), Farber Lipogranulomatosis (305), Gangliosidoses (66), Gaucher Disease (1,277), Globoid Cell Leukodystrophy (1,140), Niemann-Pick Diseases (596), Sea-Blue Histiocyte Syndrome (31).
  4. Clinical Trials ClinicalTrials.gov : at least 6 including 2 Completed, 2 Recruiting


  

        

                    


    Computing Expert Listing ...

);